Study Validates NuVasive’s Porous PEEK Cohere

By Julie A. Vetalice

NuVasive announced results of the study, "Early Outcomes of Anterior Cervical Discectomy and Fusion Using Porous PEEK™ Interbody Fusion Device," demonstrating that the company's patented porous polyetheretherketone (PEEK) technology is a clinically viable alternative to improve osseointegration and fusion rates of interbody implants to treat degenerative disc disease.

The study tracked 31 female and 19 male degenerative disease patients with an average age of 60 who underwent anterior cervical discectomy and fusion with a Cohere® device, with 100% of participants experiencing positive results. Thirteen subjects had previous unsuccessful anterior cervical fusion. All who underwent revision with Cohere achieved fusion at six months post-op. At 12 months post-op, all 50 patients demonstrated improved motion, decreased neck pain and average disc height increased by more than 4 mm as well as radiographic fusion.

Source: NuVasive, Inc.

Product Labels: Spinal Fusion

Tags: Trial/Study